Cargando…

Advances in heterocyclic chemistry. Volume 140 /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Scriven, Eric F. V., Ramsden, Christopher A., 1946-
Formato: eBook
Idioma:Inglés
Publicado: [S.l.] : Academic Press, 2023.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Intro
  • Advances in Heterocyclic Chemistry
  • Copyright
  • Contents
  • Contributors
  • Preface
  • Chapter One: The application of the Fischer indole synthesis in medicinal chemistry
  • 1. Introduction
  • 2. Mechanism of the Fischer indole synthesis
  • 2.1. Catalysis of the Fischer indole synthesis
  • 2.2. Regioselectivity of the Fischer indole synthesis
  • 2.2.1. Theoretical studies
  • 2.3. Enantioselective Fischer indole synthesis
  • 3. The scope of the Fischer indole synthesis
  • 3.1. Aryl hydrazines and hydrazones
  • 3.2. The Japp-Klingemann reaction
  • 4. Applications in medicinal chemistry
  • 4.1. Cancer
  • 4.2. Diabetes
  • 4.3. Medical imaging
  • 4.4. Osteoporosis
  • 4.5. Tuberculosis
  • 4.6. Alzheimer�s disease
  • 4.7. Antifungal, antiprotozoal, antimicrobial
  • 4.8. Depression
  • 4.9. Migraine
  • 4.10. Pesticides (herbicides and fungicides)
  • 4.11. Inflammation
  • 4.12. Flow chemistry
  • References
  • Chapter Two: Oxindole synthesis via CH activation methods
  • 1. Introduction
  • Oxindole synthesis via C-H activation methods
  • 2.1. Oxindole synthesis using carbamoyl chlorides
  • 2.2. Oxindole synthesis using anilides
  • 2.3. Oxindole synthesis using acrylamides
  • 2.4. Oxindole synthesis using propiolamides
  • 3. Concluding remarks
  • Acknowledgments
  • References
  • Chapter Three: Ring-closing metathesis in the synthesis of fused indole structures
  • 1. Introduction
  • 2. Synthesis of Fused Indoles via RCM
  • 2.1. Formation of five-membered cycles
  • 2.2. Formation of six-membered cycles
  • 2.3. Formation of seven-membered and bigger cycles
  • 3. Concluding remarks
  • Acknowledgments
  • References
  • Chapter Four: Bis-aldehydes: Versatile precursors for bis-heterocycles
  • 1. Introduction
  • 2. Synthesis of bis-aldehydes
  • 2.1. Bis-aldehydes linked to aliphatic spacers via ether linkages.
  • 2.2. Bis-aldehydes linked to aromatic or heteroaromatic spacers via ether linkages
  • 2.3. Bis-pyrazole-aldehydes linked to aliphatic or aromatic spacers via ether linkages
  • 2.4. Bis-aldehydes linked to aliphatic or aromatic spacers via ester linkages
  • 2.5. Bis-aldehydes linked to aliphatic or aromatic spacers via ether-amide linkages
  • 2.6. Bis-aldehydes linked to aliphatic spacers via ester-amide linkages
  • 2.7. Bis-aldehydes linked to piperazine linker
  • 2.8. Bis-indole-3-carboxaldehydes linked to aliphatic spacers
  • 3. Synthesis of bis-heterocycles
  • 3.1. Five-membered heterocycles
  • 3.1.1. Bis-furan
  • 3.1.2. Bis-imidazole
  • 3.1.3. Bis-thiazole
  • 3.1.4. Bis-oxazole
  • 3.1.5. Bis-triazole
  • 3.2. Six-membered heterocycles
  • 3.2.1. Bis(pyridine)
  • 3.2.2. Bis-pyrimidine
  • 3.2.3. Bis(di(uracil))
  • 3.2.4. Bis-1,2,4-triazine
  • 3.3. Synthesis of fused bicyclic system
  • 3.3.1. Fused [5-6] systems: Two heteroatoms
  • 3.3.1.1. Bis(di(1H-indole)
  • 3.3.1.2. Bis(benzimidazoles) and bis(benzothiazoles)
  • 3.3.1.3. Bis(pyrazolo[1,5-a]pyridine)
  • 3.3.2. Fused [5-6] systems: Three heteroatoms
  • 3.3.2.1. Imidazo[4,5-b]pyridine
  • 3.3.2.2. Pyrano[2,3-c]pyrazole
  • 3.3.3. Fused [6-6] systems: One heteroatom
  • 3.3.3.1. Bis(2H-chromene)
  • 3.3.3.2. Bis(di-2H-chromen-2-one)
  • 3.3.3.3. Bis-4H-chromeneone
  • 3.3.3.4. Bis-tetrahydroquinolines
  • 3.3.4. Fused [6-6] systems: Three heteroatoms
  • 3.3.4.1. Bis-(pyrimido[5,4-d]pyrimidine)
  • 3.4. Synthesis of fused tricyclic system
  • 3.4.1. Fused [5-5-6] systems: Five heteroatoms
  • 3.4.1.1. Bis(dipyrazolo-pyridine)
  • 3.4.2. Fused [5-6-6] systems: Three heteroatoms
  • 3.4.2.1. [1,2,4]Triazolo[3,4-a]isoquinoline
  • 3.4.3. Fused [5-6-6] systems: Four heteroatoms
  • 3.4.3.1. 1,4-Dihydropyrazolo[4,3:5,6]pyrano[2,3-b]pyridines
  • 3.4.3.2. [1,2,4]Triazolo[5,1-b]quinazolines.
  • 3.4.4. Fused [6-5-6] systems: Four heteroatoms
  • 3.4.4.1. Pyrido[2,3:3,4]pyrazolo[1,5-a]pyrimidines
  • 3.4.5. Fused [6-6-6] systems: One heteroatoms
  • 3.4.5.1. Bis(hexahydro-1H-xanthene)
  • 3.4.5.2. Bis(5H-acridines)
  • 3.4.5.3. Bis(pyrido-isoquinoline)
  • 3.4.6. Fused [6-6-6] systems: Two heteroatoms
  • 3.4.6.1. Bis(3H-chromeno[3,4-c]pyridine)
  • 3.4.6.2. Pyrano[3,2-c]chromenes
  • 3.4.6.3. Bis(chromeno[2,3-b]pyridine)
  • 3.4.7. Fused [6-6-6] systems: Three heteroatoms
  • 3.4.7.1. Bis(pyrimido-quinoline)
  • 3.4.8. Fused [6-6-6] systems: Five heteroatoms
  • 3.4.8.1. Pyrido[2,3-d:6,5-d�]dipyrimidine
  • 3.5. Synthesis of fused tetracyclic system
  • 3.5.1. Fused [6-6-6-5] systems: One heteroatoms
  • 3.5.1.1. 1H-Phenanthro[9,10-d]imidazole
  • 3.5.2. Fused [6-5-6-6] systems: Three heteroatoms
  • 3.5.2.1. Bis(indino-pyrido-pyrimidine)
  • 3.5.2.2. Benzo[4,5]imidazo[2,1-b]quinazoline
  • 3.5.3. Fused [6-6-6-6] systems: One heteroatom
  • 3.5.3.1. Bis(dihydro-8H-benzo[a]xanthene
  • 3.6. Synthesis of fused pentacyclic system
  • 3.6.1. Fused [6-6-6-6-6] systems: One heteroatom
  • 3.6.1.1. Dibenzo[a,j]xanthen
  • 3.6.2. Fused [6-6-6-6-6] systems: Two heteroatoms
  • 3.6.2.1. Bis(pyrano[3,2-c:5,6-c]dichromene
  • 4. Conclusions
  • References
  • Chapter Five: The literature of heterocyclic chemistry, Part XX, 2020
  • 1. Introduction
  • 2. General sources and topics
  • 2.1. General books and reviews
  • 2.1.1. Textbooks and handbooks
  • 2.1.2. Annual reports
  • 2.1.3. Specialized reports devoted to one or several recent years
  • 2.1.4. History of heterocyclic chemistry, biographies
  • 2.1.5. Bibliography of monographs and reviews
  • 2.2. General topics by reaction type
  • 2.2.1. General sources and topics
  • 2.2.2. Structure and stereochemistry
  • 2.2.2.1. Stereochemical aspects.
  • 2.2.2.2. Betaines and other unusual structures, in particular, N-heterocycli carbenes (NHC)
  • 2.2.3. Reactivity
  • 2.2.3.1. General topics
  • 2.2.3.2. Reactions with electrophiles and oxidants
  • 2.2.3.3. Reactions with nucleophiles and reducing agents
  • 2.2.3.4. Reactions toward free radicals, carbenes, etc
  • 2.2.3.5. Cross-coupling and related reactions
  • 2.2.3.6. Heterocycles as intermediates in organic synthesis
  • 2.2.3.7. Organocatalysts
  • 2.2.4. Synthesis
  • 2.2.4.1. General topics and nonconventional synthetic methodologies
  • 2.2.4.2. Synthetic strategies and individual methods
  • 2.2.4.2.1. General problems
  • 2.2.4.2.2. Synthetic application of photo reactions and alternative energy input
  • 2.2.4.2.3. Synthetic application of metal-catalyzed reactions
  • 2.2.4.2.4. Synthesis of heterocycles via cycloaddition and multicomponent reactions
  • 2.2.4.2.5. Miscellaneous methods
  • 2.2.4.3. Versatile synthons and specific reagents
  • 2.2.4.4. Ring synthesis from nonheterocyclic compounds
  • 2.2.5. Properties and applications (except drugs and pesticides)
  • 2.2.5.1. Dyes and intermediates
  • 2.2.5.2. Substances with luminescent and related properties
  • 2.2.5.3. Organic conductors and photovoltaics
  • 2.2.5.4. Coordination compounds
  • 2.2.5.5. Polymers
  • 2.2.5.6. Ionic liquids
  • 2.2.5.7. Miscellaneous
  • 2.3. Specialized heterocycles
  • 2.3.1. Nitrogen heterocycles (except alkaloids)
  • 2.3.2. Oxygen heterocycles
  • 2.3.3. Sulfur and selenium heterocycles
  • 2.4. Natural and synthetic biologically active heterocycles
  • 2.4.1. General sources and topics
  • 2.4.1.1. Biological functions of natural and synthetic bioactive heterocycles
  • 2.4.1.2. General approaches to syntheses of biologically active heterocycles
  • 2.4.1.3. Total syntheses of natural products
  • 2.4.2. Alkaloids
  • 2.4.2.1. General
  • 2.4.2.2. Synthesis.
  • 2.4.2.3. Individual groups of alkaloids
  • 2.4.3. Drugs
  • 2.4.3.1. General
  • 2.4.3.1.1. Antibacterial activity
  • 2.4.3.1.2. Antitumor activity
  • 2.4.3.1.3. CNS targeted drugs
  • 2.4.3.1.4. Anti-HIV activity
  • 2.4.3.1.5. Antimalarial and related activity
  • 2.4.3.1.6. Antitubercular activity
  • 2.4.3.1.7. Cardiovascular activity
  • 2.4.3.1.8. Receptor antagonisting and relative activities
  • 2.4.3.2. Individual substances and groups of compounds
  • 2.4.4. Miscellaneous
  • 2.4.4.1. Enzymes, coenzymes, and their models
  • 2.4.4.2. Amino acids and peptides
  • 2.4.4.3. Plant metabolites
  • 2.4.4.4. Heterocycles produced by marine organisms
  • 2.4.4.5. Other natural products
  • 3. Three-membered rings
  • 3.1. One heteroatom
  • 3.1.1. One nitrogen atom
  • 3.1.2. One oxygen atom
  • 4. Four-membered rings
  • 4.1. One nitrogen atom
  • 4.2. One oxygen or Sulfur atom
  • 5. Five-membered rings
  • 5.1. One heteroatom
  • 5.1.1. One nitrogen atom
  • 5.1.1.1. Monocyclic pyrroles and hydropyrroles
  • 5.1.1.2. Porphyrins and related systems
  • 5.1.1.3. Indoles, carbazoles, related systems, and hydrogenated derivatives
  • 5.1.1.4. Isoindoles (including phthalocyanins and porphyrazines)
  • 5.1.1.5. Pyrroles annulated with heterocycles
  • 5.1.2. One oxygen atom
  • 5.1.2.1. Furans
  • 5.1.2.2. Annulated furans
  • 5.1.3. One Sulfur Atom
  • 5.2. Two heteroatoms
  • 5.2.1. Two nitrogen atoms
  • 5.2.1.1. Pyrazoles and annulated pyrazoles
  • 5.2.1.2. Imidazoles and annulated imidazoles
  • 5.2.2. One nitrogen and one oxygen atom
  • 5.2.2.1. 1,2-Heterocycles
  • 5.2.2.2. 1,3-Heterocycles
  • 5.2.3. One nitrogen and one sulfur atom
  • 5.2.4. Two oxygen atoms
  • 5.3. Three heteroatoms
  • 5.3.1. Three nitrogen atoms
  • 5.3.2. Two nitrogen atoms and one oxygen or sulfur atom
  • 5.4. Four heteroatoms
  • 6. Six-membered rings
  • 6.1. One heteroatom
  • 6.1.1. One nitrogen atom.